Q4 2023 Capricor Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to Capricor Therapeutics' fourth-quarter 2023 earnings call. (Operator Instructions)
This call is being recorded on Thursday, February 29, 2024.
I would now like to turn the conference over to AJ Bergmann, CFO of Capricor. Please go ahead.
Thank you, and thank you for joining today. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy safety and intended utilization of our product candidates; our future R&D plans, including our anticipated conduct and timing of preclinical and clinical studies; our enrollment of patients in our clinical studies; our plans to present or report additional data; our plans regarding regulatory filings, potential regulatory developments involving our product candidates; manufacturing capabilities; potential milestone payments; our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |